Tag Archives: International Raising C. diff. Awareness

Highlights Of the Latest Advances In the Battle Against the Deadly Pathogen – Dale Gerding, MD

p1400480

TO READ THIS ARTICLE IN ITS ENTIRETY AS PUBLISHED IN THE MD MAGAZINE — PLEASE CLICK ON THE FOLLOWING LINK TO BE REDIRECTED:

 

http://www.mdmag.com/medical-news/c-diff-foundation-highlights-latest-advances-in-the-battle-against-the-deadly-pathogen

In September, researchers, health care workers, and industry and patient advocates convened for the 4th Annual International Raising C. diff Awareness Conference and Health Expo in Atlanta.

Clifford McDonald, MD, Associate Director for Science in the Division of Healthcare Quality Promotion at the Centers for Disease Control and Prevention (CDC), chaired the conference. In his role at the CDC, McDonald’s at the forefront of efforts to prevent and treat the infection – one the CDC has declared among the most urgent drug-resistant threats that we currently face.

“It’s my firm belief that we are on the threshold of a new era in better diagnosis, treatment, and prevention approaches. At the CDC, we deal with statistics, but there are faces behind those numbers. At the heart of every infection is a patient who deserves our competence, our empathy, and our passion,” said McDonald.

One of those faces, Roy Poole, is a volunteer patient advocate for the  C Diff Foundation. After retiring from a career in the Air Force, Poole led a healthy, active lifestyle as an avid outdoors-man in Colorado before antibiotics prescribed for a routine dental procedure set the stage for CDI. In the medical community, his symptoms were met with disbelief and inappropriate treatment.

“Three weeks after leaving the hospital, I walked into my (previous) primary care physician, and asked for an order to have a stool sample taken to determine if Toxins A or B were present. His response was, ‘Are you still having problems with that?’ Clearly, there is a need for more education about C. diff among physicians,” said Poole.

CDI is a formidable opponent. However, with the newly focused attention on discovering ways to disable the bacteria and cohesive public health approaches aimed at prevention, presenters from government, academia and industry offered five key reasons we can win the battle against C. diff:

Antibiotic stewardship efforts are gaining a foothold.
Statistics present a chilling picture: 453,000 new cases and an estimated 30,000 deaths each year. It’s likely that those numbers grossly underestimate the true impact of CDI, since it’s what we know from death certificate reporting.

However, we are seeing that rates may have peaked after a long plateau. Mark Wilcox, MD, Head of Microbiology at Leeds Teaching Hospital, Professor of Medical Microbiology at University of Leeds, and the lead on Clostridium difficile for Public Health England in the United Kingdom, has demonstrated a 70% reduction in cases in England in just 7 years. This was after a concerted effort that Wilcox spearheaded surrounding antibiotic stewardship, specifically addressing a reduction in unnecessary prescribing of fluoroquinolones and cephalosporin antibiotics.

Commonly prescribed antibiotics disrupt the protective microbiota (the normal bacteria of the gut) and leave it vulnerable for C. diff colonization. “There was a concerted effort that went beyond lip service and truly embraced the principles of improved surveillance, more accurate diagnostics, enhanced infection prevention measures to use antibiotics more wisely and to limit transmission and careful treatment,” said Wilcox.

High rates of CDI are always associated with the use of certain antibiotics: clindamycin, cephalosporin, and fluoroquinolones. Research has shown that lower respiratory tract infections and urinary tract infections account for more than 50% of all in-patient antibiotics use. But are these really necessary?

“We know that antibiotics are overused and misused across every healthcare setting. At least 30% of antibiotic prescriptions are unnecessary – and this equates to 47 million unnecessary antibiotic prescriptions per year written in doctors’ offices, hospital outpatient departments, and emergency departments. We have a lot of work to do, and CDC is actively working to reduce unnecessary antibiotic use,” said Arjun Srinivasan, MD at the CDC. “Stopping unnecessary antibiotics is the single most effective thing we can do to curb C. diff infections in the United States. This is something that we can do today.”

Srinivasan acknowledged that telling patients that they can’t have a prescription for an antibiotic might result in some pushback. “Patient satisfaction scores are a very real concern. When someone is sick and takes a day off work, they’re not leaving without a prescription – especially when the last provider wrote one for their same symptoms,” he said. “But this is a new day, and it’s up to the physician to educate their patients and stay strong.”

Hospitalists have access to accurate, inexpensive and quick diagnostic tests that can lead to targeted, effective treatment. This can arm the treating physician and patient with information that can put patients on a path to recovery without feeling like they are being dismissed.

Emerging guidance reflects important advances in research and development.

Most recently published in 2010, the Society for Healthcare Epidemiology of America (SHEA) and Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for C. diff are currently under review. This is critical because of the number of physicians still treating with metronidazole first, despite the fact that the largest randomized controlled clinical trial has shown that vancomycin is more effective.

“Since 2010, the landscape has changed dramatically,” said Stuart B. Johnson, MD, Professor, Department of Medicine, Loyola University, and Researcher at the Hines VA Hospital in Chicago.

“The past few years have ushered in a new age of understanding how and where C. diff colonizes, and the damaging toxins A and B that it produces.”

Considering that 25-30% of patients experience a CDI recurrence, it’s evident that metronidazole unnecessarily contributes to the failed treatment outcomes for patients. Metronidazole is less expensive, but has more side effects than oral vancomycin and is less effective in treating CDI.

Johnson provided an overview of the dramatic advances this space has seen in just the past few years.

Limitations of current guidelines include:
•       No mention of fidaxomicin, a narrow-spectrum antibiotic, which in 2011 was the first medication approved in 25 years for the treatment of C. diff associated diarrhea
•       Limited evidence for recommendations to treat severe, complicated CDI
•       Limited evidence for recommendations on recurrent CDI
•       Little mention of Fecal Microbiota Transplant (FMT)

########################

5.  Patient advocacy and awareness efforts can alter the course of CDI.
CDI survivors shared their experiences along their emotional journey – fear, disbelief, isolation, and depression. They also expressed gratitude at the validation, information and support they received from the patient advocacy community. Perhaps the greatest gift they have received is the empowerment to question their physicians about the necessity of antibiotics they have been prescribed in terms of risk of CDI.

“The hospital where I was treated initially seemed eager to have me leave. They offered no additional help. The C diff Foundation has been my greatest source of help. In turn, I feel I help myself cope best, when I help others to cope with the disease,” said Poole.

TO READ THIS ARTICLE IN ITS ENTIRETY AS PUBLISHED IN THE MD MAGAZINE 

PLEASE CLICK ON THE FOLLOWING LINK TO BE REDIRECTED —- THANK YOU

http://www.mdmag.com/medical-news/c-diff-foundation-highlights-latest-advances-in-the-battle-against-the-deadly-pathogen

 

Dale Gerding, MD, FACP, FIDSA, is Professor of Medicine at Loyola University Chicago, Research Physician at the Edward Hines Jr. VA Hospital. Additionally, Gerding is an infectious disease specialist and hospital epidemiologist, past president of the Society for Healthcare Epidemiology of America and past chair of the antibiotic resistance committee of SHEA. He is a fellow of the Infectious Diseases Society of America and past chair of the National and Global Public Health Committee and the Antibiotic Resistance Subcommittee of IDSA. His research interests include the epidemiology and prevention of Clostridium difficile, antimicrobial resistance, and antimicrobial distribution and kinetics.

The paper, “Burden of Clostridium difficile Infection in the United States,” was published in the New England Journal of Medicine.

The study, “Changing epidemiology of Clostridium difficile infection following the intriduction of a national ribotyping-based surveillance scheme in England,” was published in the journal Clinical Infectious Diseases.

The study, “Prevalence of antimicrobial use in US acute care hospitals,” was published in JAMA.

The paper, “Vancomycin, metronidazole, or toleyamer for Clostridium difficile infection: results from two multinaionalm randomized, controlled trials,” was published in Clinical Infectious Diseases.

The study, “A Randomized Placebo-controlled Trial of Saccharomyces boulardii in Combination with Standard Antibiotics for Clostridium difficile disease,” was published in JAMA.

Veronica “Raunnie” Edmond, Author, Health Coach, C.diff. And Breast Cancer Survivor Raises CDI Awareness

veronica-edmond

 

Veronica “Raunnie” Edmond, Author, Health Coach,
C Diff Foundation Volunteer Patient Advocate, C. diff. and
Stage 3 Breast Cancer Survivor joined us on
September 20th, 2016, at the
4th Annual International Raising C. diff. Awareness Conference and Health Expo in Atlanta, Georgia.

Veronica bravely shared her tormenting, painful experience encountered with a C. difficile infection while simultaneously undergoing  treatment for Breast Cancer.

We are grateful for her full recovery from this life-threatening diagnosis and infection and for the positive attitude Veronica has in promoting breast health, wellness, and raising C.diff. awareness.

Thank you Veronica and to all fellow C.diff.  Survivors  www.cdiffsurvivors.org  sharing their inspirational journey

“No one can do this alone ~ All of us can do this together.”

C.diff. Survivor

C.diff. Survivor

 

 

 

 

 

Thanksgiving is a great time to reflect on the year’s blessings, reconnect with family, share a big meal and sometimes get indigestion. Often times, the overindulgence of a variety of foods may cause an upset stomach or stomach bug.

To be blunt, the rapid expansion of the stomach and foods rich in creams, sugar, and fat can cause gas, bloating and diarrhea. In most cases, the stomach discomfort is temporary and, with over-the-counter medicine, the symptoms are gone.

When should you be concerned, if the usual remedies are ineffective to control diarrhea?

One of the answers is when the pain from diarrhea, abdominal cramps and fever is so severe that it lands you in the emergency room. In Veronica “Raunnie” Edmond’s case, she was already hospitalized during her second round of chemotherapy for an aggressive form of stage 3 breast cancer.

Please click on the link below to be redirected to this most admirable story shared by Veronica with Marie Y. Lemelle, Contributing Columnist at Wave Newspapers

http://wavenewspapers.com/health-matters-a-case-of-diarrhea-that-almost-turned-deadly/

 

MarieLemelle2016

Marie Y. Lemelle, MBA, a public relations consultant, is the owner of Platinum Star PR and can be reached on Twitter @PlatinumStar, or Instagram @PlatinumStarPR. Send “Health Matters” related questions to healthmatters@wavepublication.com and look for her column in The Wave.

November 29th Is Giving Tuesday – A Global Day Of Giving and Your Support Grows and Strengthens the C Diff Foundation

giving-tuesday

#GivingTuesday

Giving Tuesday Is a global day dedicated to giving back.

On Tuesday, November 29th , 2016  Charities, Families, Businesses, Community centers, and Students around the world will come together for one common purpose: to celebrate generosity and to give.

 

giving tuesday

#GivingTuesday was founded in 2012 by New York’s 92nd Street Y in partnership with the United Nations Foundation. Together, with a team of influential and founding partners together launched a global movement that has engaged over 10,000 organizations worldwide.

Remember the C Diff Foundation in your Giving Tuesday efforts. Your gift is tax deductible and it will support patients touched by the life-threatening C. diffiicle infection,  their families, communities and the many  programs dedicated in Raising C. diff. Awareness™   by providing information and support — from villages to cities — worldwide.

We appreciate you and all that you do for the good of others.

To Donate please visit  the C Diff Foundation Website   www.cdifffoundation.org

and choose the tab at the top of the page —

https://cdifffoundation.org/donate/

 

Thank you for your continued support and we are grateful for your generosity.

C. diff. Awareness Across the Globe

cdiffawarenessribbon

Beginning November 1st,

join the C Diff Foundation in

“Raising C. diff.  Awareness.”

Let’s begin with promoting C. difficile prevention to share in witnessing a decrease in C. difficile infections worldwide.

Ways to PREVENT acquiring a C. diff. infection:

HAND-WASHING remains the #1 course of action in infection prevention.

Knowing how and when to wash hands is also important.

Correct Hand-washing steps to follow:

  • Wet your hands with clean, running water (warm or cold), turn off the tap, and apply soap.
  • Lather your hands by rubbing them together with the soap. Be sure to lather the backs of your hands, between your fingers, and under your nails.
  • Scrub your hands for at least 30 seconds. Need a timer? Hum the “Happy Birthday” song from beginning to end twice.
  • Rinse your hands well with water.
  • Dry your hands using a clean towel.
  • Turn off faucets with a clean dry towel, and wipe hands with a clean dry towel.

WHEN is it a good time to wash hands?

  • Before, during, and after handling and preparing food.
  • Upon Entering a Patient’s room and Before Existing a Patient’s room.
  • Before and after eating.
  • Before and after patient care.
  • Before and after treating a cut or wound.
  • Before  exiting a restroom.
  • After changing diapers.
  • After blowing your nose, coughing, or sneezing.
  • After petting a pet or any livestock animals.
  • After touching garbage.
  • AND OFTEN.

Limit Antibiotic Use — Discuss Symptoms With Healthcare Providers.

The Centers of Disease Control and Prevention recommends infection control protocols be shared between healthcare professionals and long-term facility administrators for the safety of the patient, visitors, and other patient’s safety.

Question the necessity of antibiotics to treat symptoms.  Unnecessary use of antibiotics raises the risk of acquiring a C. difficile infection.  Remember antibiotics do not effect viruses.  Healthcare professionals; confirming a bacterial infection before prescribing antibiotic course of treatment is advised.

Take the Antibiotic “Resistance Fighter” Pledge

How to be a resistance fighter:  Limit the use of Antibiotics! Understand that antibiotics are only effective against bacteria and not viruses: colds, flu and most coughs are caused by viruses and will get better on their own.  Treat your flu and cold symptoms and let your immune system fight the virus.  Antibiotics will not help you get better quickly, and may give you side effects such as diarrhea and thrush. They can also lead to acquired C. diff. infections. They won’t stop your virus spreading to other people only YOU can do that with good hand hygiene.  Don’t ask for antibiotics , instead ask your doctor about the best way to treat your symptoms.   If you are prescribed antibiotics ask your doctor about the risks and benefits and always take them exactly as prescribed. Never take someone else’s antibiotics, always speak with your Primary Care Physician (PCP) or healthcare professional when symptoms linger or worsen.

Let us all take the “Resistance Fighter” Pledge and feel free to share the pledge with            everyone you know

I will not expect antibiotics for colds and flu as they have no effect on viruses.
I will take antibiotics as directed IF I am prescribed them, and not ask for them.
I will practice good hygiene, making hand washing #1, and help stop giving germs a free ride.

Now we can ALL spread knowledge, not infections and encourage others to join the fight against antibiotic resistance.

“Get Smart: Know When Antibiotics Work” CDC Campaign :

Get Smart About Antibiotics Week has been an annual effort to coordinate the work of CDC’s Get Smart: Know When Antibiotics Work campaign, state-based appropriate antibiotic use campaigns, non-profit partners, and for-profit partners during a one week observance of antibiotic resistance and the importance of appropriate antibiotic use. The campaign organized its first annual Get Smart About Antibiotics Week in 2008. CDC’s Get Smart campaign, housed in the National Center for Immunization and Respiratory Diseases, collaborated with state-based appropriate antibiotic use campaigns and non-profit and for-profit partners. The success of the pilot year was measured by 1) dissemination of educational materials and messages, 2) partner satisfaction, and 3) media interest. A robust evaluation of the pilot week determined that each of these goals was met and exceeded. This was followed by other successful Get Smart About Antibiotics Week observances.

During November 14-20th, 2016 —  the Annual Get Smart About Antibiotics Week will be observed. As in past years, the effort will coordinate work of CDC’s Get Smart: Know When Antibiotics Work campaign, state-based appropriate antibiotic use campaigns, non-profit partners, and for-profit partners during a one week observance of antibiotic resistance and the importance of appropriate antibiotic use. As with the past observances, messages and resources for improving antibiotic use in  healthcare settings from CDC’s Get Smart for Healthcare campaign will be included. Get Smart for Healthcare is a program housed in CDC’s National Center for Emerging and Zoonotic Infectious Diseases.

  • Ask your physician questions such as, “Do I really need an antibiotic?”
  • Bacteria only, not viruses (common cold, flu), can be killed by antibiotics.
  • Complete the entire course of prescribed antibiotics, even if you feel better midway through.

Antibiotic resistance occurs when bacterial changes reduce or eliminate an antibiotic’s ability to kill the bacteria.

The Association of Professionals in Infection Control and Epidemiology (APIC)  recommends the following:

  • Take antibiotics only and exactly as instructed by your healthcare provider.
  • Only take antibiotics prescribed for you.
  • Do not save or share antibiotics prescribed to you.
  • Do not pressure your healthcare provider to prescribe you antibiotics.

C. diff. Testing:  When a patient presents symptoms (diarrhea with abdominal cramping/pain, fatigue, fever) ordering a C. difficile stool test to rule out a C. diff. infection is beneficial, especially if the patient has been treated with antibiotics within ninety-days.

Environmental Safety:  Disinfecting a patient’s room, treated for a positive C. difficile infection, with a bleach or Federal EPA registered spore-killing product will help eliminate      C. difficile spores from being spread to another patient’s room.  Environmental safety is also an important matter in home-care.  Cleaning all high-touch areas in both long-term and acute care facilities, and home environments will help decrease the spread of this infection.  (High-touch surfaces: light switches, door knobs/handles, bed-side commodes, bathroom hand rails, commode, sink and sink handles, counter-tops, floors, bath-tubs, showers, canes, wheel-chairs, and all medical equipment in a patient’s room).

Personal Protection: ISOLATION: Visitors and Environmental professionals, wear proper personal protection equipment when treating and cleaning areas/rooms of a     C. difficile patient.  (gloves, gowns, shoe coverings, protective eye wear if using using spray solutions).

Patient Isolation:  Contact Precautions: Protect the patient and others by keeping a C. difficile patient in isolation in long-term and acute care facilities.  This will prevent the spread of infection to others and other areas within the facilities.

Communication:  If a patient is being transferred from either a long-term or acute care facility, communicate to the facility intake personnel the patient’s C. diff. infection and necessary infection control protocols to be implemented for the patient and other patient’s safety.

The CDC has been sharing public announcements regarding the use of Antibiotics for both healthcare professionals and patients alike.  Colds, Ear and Sinus symptoms may be caused by a virus, not bacteria.  Taking antibiotics to treat a virus makes antibiotic medications less effective when they are needed while raising the risk of acquiring a C. difficile infection.  Limit the use of Antibiotics to reduce the risk of acquiring a C. difficile infection  (Bacterial infections and the treatment of symptoms will be determined and should be followed by the treating healthcare professionals). * November 17-23rd, 2014 join the CDC’s Get Smart: Know When Antibiotics Work campaign.

“None of us can do this alone…..all of us can do this together”

For additional C. difficile information, review the Infection Prevention categories available on the website :   http://www.cdifffoundation.org

 

 

 

Sources: CDC

C Diff Foundation Global Network Welcomes Ron Romano, RN

Welcome cloud

We are pleased to welcome Ron Romano, RN to the C Diff Foundation Global Network.

Ron Romano, RN  presides as Infection Prevention Advocate.

 

Ron has certifications from the following organizations :

      • American Association for LTC Nursing – Co-founder Past President – 2007- 2015
      • American Association for Safe Patient Handling – Board Member 2010-2012
      • Association for Professionals in Infection Control & Epidemiology – Current Member
      • Safety Specialist LTC – Certification – Current

C. difficile Infections are no stranger to Ron as his family members have also been touched by this infection.  His background in healthcare and passion for Infection Prevention and Epidemiology is an asset to many.  Ron is the Owner, President and CEO of Safety Net LLC in Cincinnati, Ohio.

Safety Net is a national healthcare safety consulting and distribution company providing unique product solutions to mitigate risk associated to infections. We serve acute care hospitals, post-acute and home-care. Our solutions protect our healthcare workers and those under their care.

Ron has also been the Past-President in the following organizations:

American Association for LTC Nursing (AALTCN) 07-15    The AALTCN is a professional organization that supports all levels of caregivers providing career ladder with supporting education, certifications and resources. AALTCN has recently merged with the American Association for Nurse Assessment Coordinators to form the largest professional nursing organization in long term care.

Health Education Network – 07-15,  Co-owner – President

Health Education Network is a medical publication company that provides Nursing education for all levels of caregivers on a variety of topics for LTC. Certificate programs are available for Staff Development Coordinators, Nurse Assessment Coordinators, Director of Nursing in LTC, RN and LPN in LTC.

National Association Director of Nursing Administration (NADONA/LTC) Cincinnati, Ohio 01-07

NADONA/LTC is a professional organization representing Directors of Nursing, Assistant Directors of Nursing and Clinical Managers in long-term care. NADONA/LTC has 38 state chapters nationally and internationally in Canada.

We welcome Ron to the C Diff Foundation and appreciate his healthcare background to join us in promoting Infection prevention and C. diff. Awareness worldwide with fellow members

It’s Giving Tuesday – A Global Day Of Giving and Your Support Grows and Strengthens the C Diff Foundation

Giving Tuesday

#GivingTuesday

is a global day dedicated to giving back. On Tuesday, December 1, 2015, charities, families, businesses, community centers, and students around the world will come together for one common purpose: to celebrate generosity and to give.

 

giving tuesday

#GivingTuesday was founded in 2012 by New York’s 92nd Street Y in partnership with the United Nations Foundation. Together, with a team of influential and founding partners together launched a global movement that has engaged over 10,000 organizations worldwide.

Remember C Diff Foundation in your Giving Tuesday efforts. Your gift is tax deductible and will support patients touched by the life-threatening C. diffiicle infection,  their families,  communities and the many  programs dedicated in Raising C. diff. Awareness™   by providing information and support worldwide.

We appreciate you and all that you do.

For donations, please visit  the C Diff Foundation  http://www.cdifffoundation.org

and choose the top tab

“How You Can Help ♥ Donate Today” 

 

Thank you for your continued support and we are grateful for your generosity.